- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06745635
A Multifaceted Intervention on Reducing Immunization Errors (THEIA)
A Multifaceted Intervention on Reducing Immunization Errors: a Pragmatic, Stepped-wedge, Cluster Randomized Trial
The goal of this trial is to reduce the general error related to vaccines and immunizations (composited on secondary endpoint), after 11 moths of folow-up after cluster randomization and stepped wedge on primary care on brazilian public health.
The main questions it aims to answer are:
- To evaluate the effectiveness of a multifaceted intervention in vaccination rooms in reducing vaccination errors.
- To describe the rate of adverse events following immunization (AEFI) and the associated factors.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Researchers will compare two times in a Stepped Wedge design:
Usual Care :All sites will follow the standard practices for vaccine management and immunization in health units with vaccination rooms during 1 month.
All sites will be randomized into 11 steps (corresponding to the number of stages required to complete the 12-month study). At each step, 8 clusters (each containing one immunization service within a primary care facility) will receive the intervention."
Multifaceted Strategy :*This time will implement a multifaceted quality improvement and process strategy composed of:
- Video-based training on vaccine management.
- Development of an optimized Cold Chain Manual, streamlining guidelines for vaccine handling.
- Technical documents providing comprehensive guidance on the appropriate management of vaccines and their respective immunization schedules.
- Technical documentsaddressing the management of errors identified post-vaccination and offering recommendations for public guidance.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Antonio C Mattos, MSc
- Phone Number: +55 (11) 2151-1233
- Email: antonio.mattos@einstein.br
Study Locations
-
-
-
Sao Paulo, Brazil
- Hospital Israelita Albert Einstein
-
Contact:
- Henrique Fonseca
- Phone Number: +55 (11) 2151-1233
- Email: henrique.fonseca@einstein.br
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Cluster Inclusion Criteria
- Health units with vaccination rooms administering at least 2,000 doses of vaccines/immunobiologicals per month,
Cluster Exclusion Criteria
- Primary health units that do not provide consistent vaccination services to the population.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Usual Care Group
This arm will continue to follow the routine activities and standard procedures established by the public health system.
|
Usual care for immunizations.
|
|
Other: Multifaceted Intervention Group
This group will implement a multifaceted quality improvement and process strategy composed of: Video-based training on vaccine management. Development of an optimized Cold Chain Manual, streamlining guidelines for vaccine handling. Technical documents providing comprehensive guidance on the appropriate management of vaccines and their respective immunization schedules. Technical documents addressing the management of errors identified post-vaccination and offering recommendations for public guidance |
The multifaceted quality improvement intervention includes: video-based training on vaccine management in SUS, an optimized Cold Chain Manual schema, technical documents on proper vaccine handling and immunization schedules, and checklists for managing post-vaccination errors and corrective procedures.
Videos will focus on six key points (right person, vaccine, dose, time, route, and documentation), with each lasting about 2 minutes and accessible on-demand.
The Cold Chain schema will cover storage, monitoring, transport, conservation, and handling, with checklists for each category.
Standardized technical documents will align with video themes, ensuring protocol adherence.
An error identification and management schema will address issues like improper vaccine administration, cold chain violations, and incorrect dosages.
This schema will be reviewed by staff and made available in health units.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reduction of overall errors attributable to vaccination and immunization processes.
Time Frame: From Randomization to the end of Follow-up (12 months)
|
The primary composite outcome is defined as the reduction of overall errors attributable to vaccination and immunization processes, including: dilution errors, administration of vaccines outside the recommended age, errors related to inappropriate intervals between doses/vaccines, errors in the use of immunobiologicals, errors related to repeated doses, administration of vaccines not recommended during pregnancy, errors in the storage and handling of vaccines and immunobiologicals, and administration of vaccines via incorrect routes.
|
From Randomization to the end of Follow-up (12 months)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
incidence of the components of the primary outcome
Time Frame: Through study completion, an average of 1 year
|
Rate of the components of the primary outcome.
|
Through study completion, an average of 1 year
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Primary Secondary Outcome - Incidence of reported Adverse Events Following Immunization
Time Frame: From Randomization to the end of Follow-up (12 months)
|
Incidence of reported Adverse Events Following Immunization (AEFI) in the studied health units-AEFIs recorded either spontaneously or through active surveillance within the health units during the study period.
|
From Randomization to the end of Follow-up (12 months)
|
|
Exploratory Objective - Economical impact of strategy for reduce the error of immunization
Time Frame: Through study completion, an average of 1 year
|
Cost-Effectiveness - Economical impact of strategy for reduce the error of immunization as basis for public vaccination policy justification -
|
Through study completion, an average of 1 year
|
Collaborators and Investigators
Collaborators
Investigators
- Study Chair: Henrique A Fonseca, ScD, PhD, Hospital Albert Einstein
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- THEIA trial
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vaccines
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedVaccines, Pneumococcal | Vaccines, Pneumococcal Conjugate Vaccine
-
PfizerCompletedVaccines | Meningococcal VaccinesUnited States
-
PfizerCompleted
-
PfizerCompleted
-
Beijing Zhifei Lvzhu Biopharmaceutical Co., LtdCompleted
-
University of Alabama at BirminghamNational Cancer Institute (NCI)Active, not recruitingPapillomavirus VaccinesUnited States
-
Vaxcyte, Inc.CompletedPneumococcal VaccinesUnited States
-
University of Maryland, BaltimoreMerck Sharp & Dohme LLCTerminatedHPV VaccinesUnited States
-
PATHCompletedMeningococcal VaccinesUnited States
Clinical Trials on Usual Care
-
Charite University, Berlin, GermanyCompletedMultiple Sclerosis | FatigueGermany
-
Charite University, Berlin, GermanyMammazentrum Hamburg am Krankenhaus Jerusalem, Germany; Dorit und Alexander...Completed
-
European Institute for Evidence Based Osteopathic...Unknown
-
Suzanna ZickUniversity of MichiganTerminatedQuality of Life | Fatigue | Lupus Erythematosus, Systemic | Sleep | Pain, ChronicUnited States
-
Centers for Disease Control and PreventionCompleted
-
University Hospital, MontpellierCompletedOsteoarthritis | Mindfulness | MBSRFrance
-
Gachon University Gil Oriental Medical HospitalKorea Health Industry Development InstituteCompletedKnee Replacement | AcupunctureKorea, Republic of
-
Mayo ClinicCompleted
-
The Miriam HospitalNational Institute on Aging (NIA)CompletedHeart FailureUnited States
-
Lawson Health Research InstituteUnknownDepression | Quality of Life | Sleep | Anxiety | Dry EyeCanada